Tenax Therapeutics TENX
NASDAQ TENX
$1.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Tenax Therapeutics (TENX) Restructuring Costs (2012 - 2014)

Updated

Tenax Therapeutics (TENX) reported Restructuring Costs of $220,715 for FY2013.

Analysis

Tenax Therapeutics (TENX) Restructuring Costs (2012 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tenax Therapeutics 76.96 Mn -371.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2014 220,715.00
Oct 31, 2013 220,715.00
Jul 31, 2013 220,715.00
Jan 31, 2013 2,941.00
Oct 31, 2012 170,298.00
Jul 31, 2012 47,476.00
API Access

Tenax Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TENX&period=max&api_key=YOUR_API_KEY